40.00
+0.22(+0.55%)
Currency In HKD
Address
No. 108, Meiliang Road
Wuxi, 214092
China
Phone
86 51081831205
Sector
Healthcare
Industry
Biotechnology
Employees
12575
First IPO Date
June 13, 2017
| Name | Title | Pay | Year Born |
| Zhisheng Chen | Chief Executive Officer & Executive Director | 9.37M | 1973 |
| Jian Dong | CEO of WuXi Vaccines | 0 | 1964 |
| Ge Li | Founder & Chairman | 0 | 1967 |
| Jijie Gu | Chief Scientific Officer & President of Global Biologics Research | 0 | 1966 |
| Xuejun Gu | Chief Technology Officer, Executive Vice President of Global Biologics Development Department & Executive Director | 0 | 1971 |
| He Wang | General Counsel, Chief Compliance Officer, SVP and Head of Legal & Compliance Department | 0 | N/A |
| Lihua Yu | COO & Senior VP | 0 | N/A |
| Angus Scott Marshall Turner | Senior VP and Head of Global BD & Alliance Management | 0 | 1968 |
| Ming Tu | Chief Financial Officer & Executive Vice President | 0 | 1969 |
| Lina Fan | Senior VP & Head of Investor Relations | 0 | N/A |
| Li Xiong | VP & Head of Global Human Resources | 0 | N/A |
WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.